Consistent with the literature [33, 35, 36], the results of the present study showed fusion of the FGFR2 gene with nine different partners, namely, TACC2, BICC1, BTBD16, WAC, HFM1, HOOK1, INPP5F, C10orf90, and WDR11, in five different types of cancer. The gene discussed is BTBD16; the disease is cancer.